Steris Stock Price, News & Analysis (NYSE:STE)

$91.09 +0.45 (+0.50 %)
(As of 02/23/2018 11:55 AM ET)
Previous Close$90.64
Today's Range$90.69 - $91.52
52-Week Range$67.55 - $93.71
Volume43,671 shs
Average Volume379,047 shs
Market Capitalization$7.65 billion
P/E Ratio31.92
Dividend Yield1.38%
Beta1.22

About Steris (NYSE:STE)

Steris logoSTERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others. Its Corporate and other segment includes the Defense and Industrial business unit.

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:STE
CUSIP85915210
Phone44-13-3238-7100

Debt

Debt-to-Equity Ratio0.46%
Current Ratio2.82%
Quick Ratio2.22%

Price-To-Earnings

Trailing P/E Ratio31.9246734199067
Forward P/E Ratio22.06
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.61 billion
Price / Sales2.96
Cash Flow$6.78 per share
Price / Cash13.43
Book Value$36.74 per share
Price / Book2.48

Profitability

Trailing EPS$2.85
Net Income$109.96 million
Net Margins9.42%
Return on Equity11.57%
Return on Assets6.80%

Miscellaneous

Employees12,000
Outstanding Shares84,850,000

Steris (NYSE:STE) Frequently Asked Questions

What is Steris' stock symbol?

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

How often does Steris pay dividends? What is the dividend yield for Steris?

Steris declared a dividend on Wednesday, February 7th. Shareholders of record on Wednesday, February 28th will be paid a dividend of $0.31 per share on Wednesday, March 28th. The ex-dividend date of this dividend is Tuesday, February 27th. This is a boost from Steris's previous dividend of $0.21. View Steris' Dividend History.

How were Steris' earnings last quarter?

Steris PLC (NYSE:STE) posted its earnings results on Wednesday, February, 7th. The medical equipment provider reported $1.12 EPS for the quarter, beating the consensus estimate of $1.07 by $0.05. The medical equipment provider earned $661.90 million during the quarter, compared to the consensus estimate of $663.17 million. Steris had a net margin of 9.42% and a return on equity of 11.57%. The firm's quarterly revenue was up 2.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.98 earnings per share. View Steris' Earnings History.

When will Steris make its next earnings announcement?

Steris is scheduled to release their next quarterly earnings announcement on Tuesday, May, 8th 2018. View Earnings Estimates for Steris.

What guidance has Steris issued on next quarter's earnings?

Steris issued an update on its FY18 earnings guidance on Wednesday, February, 7th. The company provided EPS guidance of $4.10-4.16 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.05.

Where is Steris' stock going? Where will Steris' stock price be in 2018?

5 brokers have issued twelve-month price objectives for Steris' shares. Their predictions range from $16.00 to $103.00. On average, they expect Steris' stock price to reach $80.25 in the next year. View Analyst Ratings for Steris.

Who are some of Steris' key competitors?

Who are Steris' key executives?

Steris' management team includes the folowing people:

  • Michael J. Tokich, Chief Financial Officer, Senior Vice President, Treasurer (Age 46)
  • Karen L Burton, Chief Financial Officer, Chief Accounting Officer, Vice President, Controller (Age 49)
  • J. Adam Zangerle, Company Secretary (Age 48)
  • Richard C. Breeden, Director (Age 66)
  • Bruce A. Edwards, Director (Age 62)
  • Cynthia L. Feldmann CPA, Director (Age 64)
  • Jacqueline B. Kosecoff Ph.D., Director (Age 68)
  • David Baker Lewis, Director (Age 73)

Who owns Steris stock?

Steris' stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.45%), Fisher Asset Management LLC (1.78%), ArrowMark Colorado Holdings LLC (1.75%), Bessemer Group Inc. (1.53%), American Century Companies Inc. (1.40%) and Wells Fargo & Company MN (1.30%). Company insiders that own Steris stock include Adrian Vincent Coward, Cynthia L Feldmann, Daniel A Carestio, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Institutional Ownership Trends for Steris.

Who sold Steris stock? Who is selling Steris stock?

Steris' stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., DF Dent & Co. Inc., Goldman Sachs Group Inc., Renaissance Technologies LLC, Champlain Investment Partners LLC, Frontier Capital Management Co. LLC, Bessemer Group Inc. and Copeland Capital Management LLC. Company insiders that have sold Steris company stock in the last year include Daniel A Carestio, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Insider Buying and Selling for Steris.

Who bought Steris stock? Who is buying Steris stock?

Steris' stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Congress Asset Management Co. MA, American Century Companies Inc., Daiwa Securities Group Inc., Bank of Montreal Can, Wells Fargo & Company MN, APG Asset Management N.V. and Amundi Pioneer Asset Management Inc.. View Insider Buying and Selling for Steris.

How do I buy Steris stock?

Shares of Steris can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Steris' stock price today?

One share of Steris stock can currently be purchased for approximately $91.09.

How big of a company is Steris?

Steris has a market capitalization of $7.65 billion and generates $2.61 billion in revenue each year. The medical equipment provider earns $109.96 million in net income (profit) each year or $2.85 on an earnings per share basis. Steris employs 12,000 workers across the globe.

How can I contact Steris?

Steris' mailing address is Rutherford House Stephensons Way Chaddesden, Derby X0, DE21 6LY. The medical equipment provider can be reached via phone at 44-13-3238-7100 or via email at [email protected]


MarketBeat Community Rating for Steris (STE)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  141 (Vote Outperform)
Underperform Votes:  218 (Vote Underperform)
Total Votes:  359
MarketBeat's community ratings are surveys of what our community members think about Steris and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Steris (NYSE:STE) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.602.502.602.60
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $80.25$72.33$72.00$85.00
Price Target Upside: 4.68% downside18.09% downside18.34% downside1.96% downside

Steris (NYSE:STE) Consensus Price Target History

Price Target History for Steris (NYSE:STE)

Steris (NYSE:STE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/8/2018KeyCorpReiterated RatingBuy$103.00MediumView Rating Details
2/8/2018Northcoast ResearchSet Price TargetBuy$102.00MediumView Rating Details
1/3/2018Raymond James FinancialReiterated RatingOutperform -> Market Perform$100.00HighView Rating Details
11/9/2017TD SecuritiesBoost Price TargetBuyC$14.00 -> C$16.00N/AView Rating Details
6/5/2017Wellington ShieldsDowngradeGradually Accumulate -> HoldLowView Rating Details
11/30/2016Goldman Sachs GroupInitiated CoverageNeutral$71.00N/AView Rating Details
11/4/2016JMP SecuritiesReiterated RatingBuyN/AView Rating Details
(Data available from 2/23/2016 forward)

Earnings

Steris (NYSE:STE) Earnings History and Estimates Chart

Earnings by Quarter for Steris (NYSE:STE)

Steris (NYSE STE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2018$1.20N/AView Earnings Details
2/7/2018Q3 2018$1.07$1.12$663.17 million$661.90 millionViewN/AView Earnings Details
11/1/2017Q2 2018$0.95$0.94$629.02 million$634.20 millionViewN/AView Earnings Details
8/8/2017Q1 2018$0.80$0.85$597.66 million$608.00 millionViewListenView Earnings Details
5/9/2017Q4$1.07$1.11$673.47 million$681.20 millionViewListenView Earnings Details
2/7/2017Q317$1.04$0.98$680.13 million$646.80 millionViewListenView Earnings Details
11/2/2016Q217$0.90$0.89$670.24 million$646.40 millionViewN/AView Earnings Details
8/9/2016Q117$0.77$0.79$639.04 million$638.40 millionViewListenView Earnings Details
5/18/2016Q416$1.04$0.90$701.92 million$690.30 millionViewListenView Earnings Details
2/9/2016Q316$0.94$0.98$617.35 million$618.70 millionViewN/AView Earnings Details
10/30/2015Q216$0.76$0.83$488.66 million$489.90 millionViewListenView Earnings Details
8/4/2015Q415$0.61$0.62$439.23 million$439.90 millionViewListenView Earnings Details
5/7/2015Q4$0.89$0.98$520.07 million$501.60 millionViewListenView Earnings Details
2/4/2015Q315$0.73$0.79$475.22 million$473.20 millionViewListenView Earnings Details
11/4/2014Q215$0.62$0.68$452.50 million$462.70 millionViewListenView Earnings Details
8/5/2014Q115$0.54$0.54$418.26 million$412.60 millionViewListenView Earnings Details
5/8/2014Q4$0.86$0.91$455.92 million$465.30 millionViewListenView Earnings Details
2/5/2014Q314$0.69$0.59$406.40 million$405.60 millionViewListenView Earnings Details
10/30/2013Q214$0.54$0.55$376.82 million$383.80 millionViewListenView Earnings Details
8/7/2013Q1 2014$0.56$0.44$372.69 million$367.70 millionViewListenView Earnings Details
5/7/2013Q4 2013$0.65$0.70$405.79 million$426.20 millionViewListenView Earnings Details
2/6/2013Q3 2013$0.56$0.58$368.84 million$380.40 millionViewListenView Earnings Details
10/31/2012Q213$0.52$0.53$350.23 million$356.30 millionViewN/AView Earnings Details
8/2/2012$0.44$0.53ViewN/AView Earnings Details
5/8/2012$0.60$0.59ViewN/AView Earnings Details
2/7/2012$0.60$0.58ViewN/AView Earnings Details
11/2/2011$0.57$0.50ViewN/AView Earnings Details
8/2/2011$0.50$0.46ViewN/AView Earnings Details
5/9/2011$0.62$0.61ViewN/AView Earnings Details
2/8/2011$0.58$0.57ViewN/AView Earnings Details
11/3/2010Q2 2011$0.54$0.55ViewN/AView Earnings Details
8/3/2010Q1 2011$0.45$0.46ViewN/AView Earnings Details
5/6/2010Q4 2010$0.53$0.55ViewN/AView Earnings Details
2/2/2010Q3 2010$0.47$0.69ViewN/AView Earnings Details
11/3/2009Q2 2010$0.43$0.54ViewN/AView Earnings Details
7/30/2009Q1 2010$0.41$0.43ViewN/AView Earnings Details
5/7/2009Q4 2009$0.38$0.49ViewN/AView Earnings Details
1/27/2009Q3 2009$0.37$0.53ViewN/AView Earnings Details
10/30/2008Q2 2009$0.34$0.48ViewN/AView Earnings Details
7/30/2008Q1 2009$0.27$0.43ViewN/AView Earnings Details
5/7/2008Q4 2008$0.50$0.59ViewN/AView Earnings Details
1/30/2008Q3 2008$0.38$0.35ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Steris (NYSE:STE) Earnings Estimates

2018 EPS Consensus Estimate: $4.05
2019 EPS Consensus Estimate: $4.78
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.80$0.82$0.81
Q2 20182$0.92$0.94$0.93
Q3 20182$1.06$1.11$1.09
Q4 20182$1.22$1.22$1.22
Q1 20191$0.99$0.99$0.99
Q2 20191$1.12$1.12$1.12
Q3 20191$1.28$1.28$1.28
Q4 20191$1.39$1.39$1.39
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Steris (NYSE:STE) Dividend Information

Next Dividend:3/28/2018
Annual Dividend:$1.24
Dividend Yield:1.36%
Dividend Growth:10.30% (3 Year Average)
Payout Ratio:43.51% (Trailing 12 Months of Earnings)
30.02% (Based on This Year's Estimates)
26.50% (Based on Next Year's Estimates)
Track Record:8 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Steris (NYSE:STE)

Steris (NYSE:STE) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/7/2018$0.312/27/20182/28/20183/28/2018
11/1/2017Quarterly$0.311.42%11/21/201711/22/201712/20/2017
8/8/2017Quarterly$0.311.46%8/25/20178/29/20179/28/2017
5/9/2017Quarterly$0.286/5/20176/7/20176/29/2017
2/7/2017Quarterly$0.281.67%2/24/20172/28/20173/28/2017
11/2/2016Quarterly$0.281.69%11/21/201611/23/201612/21/2016
8/9/2016Quarterly$0.281.6%8/26/20168/30/20169/27/2016
5/18/2016quarterly$0.251.43%6/6/20166/8/20166/29/2016
2/9/2016Quarterly$0.252/26/20163/1/20163/29/2016
10/19/2015quarterly$0.251.45%10/28/201510/30/201512/18/2015
8/5/2015quarterly$0.251.45%8/21/20158/25/20159/22/2015
5/7/2015quarterly$0.231.35%6/1/20156/3/20156/25/2015
2/5/2015quarterly$0.231.36%2/23/20152/25/20153/25/2015
11/5/2014quarterly$0.231.47%11/24/201411/26/201412/23/2014
8/6/2014quarterly$0.231.79%8/22/20148/26/20149/23/2014
5/14/2014quarterly$0.211.58%6/3/20146/5/20146/26/2014
2/6/2014quarterly$0.211.91%2/24/20142/26/20143/26/2014
10/30/2013$0.2111/18/201311/20/201312/18/2013
8/7/2013quarterly$0.211.91%8/26/20138/28/20139/25/2013
5/8/2013quarterly$0.191.69%5/31/20136/4/20136/25/2013
2/7/2013quarterly$0.191.93%2/25/20132/27/20133/27/2013
(Data available from 1/1/2013 forward)

Insider Trades

Steris (NYSE STE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.55%
Institutional Ownership Percentage: 89.43%
Insider Trades by Quarter for Steris (NYSE:STE)
Institutional Ownership by Quarter for Steris (NYSE:STE)

Steris (NYSE STE) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/13/2018Karen L BurtonVPSell1,500$85.59$128,385.00View SEC Filing  
1/29/2018Sudhir K. PahwaVPSell2,000$92.09$184,180.00View SEC Filing  
11/14/2017John Adam ZangerleVPSell3,650$88.00$321,200.00View SEC Filing  
10/23/2017Michael J TokichInsiderSell11,000$92.00$1,012,000.0058,588View SEC Filing  
10/4/2017Michael J TokichInsiderSell12,000$89.75$1,077,000.00View SEC Filing  
10/4/2017Walter M Rosebrough JrCEOSell10,000$90.50$905,000.00View SEC Filing  
9/8/2017Richard Martin SteevesDirectorSell156,072$87.13$13,598,553.369,362View SEC Filing  
8/16/2017Walter M Rosebrough JrCEOSell10,000$85.69$856,900.0083,270View SEC Filing  
8/15/2017Karen L BurtonVPSell3,270$85.70$280,239.0011,807View SEC Filing  
8/9/2017Mohsen SohiDirectorSell2,744$85.98$235,929.1221,816View SEC Filing  
7/3/2017Michael B WoodDirectorSell4,000$81.50$326,000.0026,131View SEC Filing  
6/16/2017Kathleen BardwellInsiderSell3,795$82.00$311,190.0020,605View SEC Filing  
6/13/2017Daniel A. CarestioInsiderSell4,745$80.08$379,979.60View SEC Filing  
6/2/2017Walter M. Rosebrough, Jr.CEOSell10,000$80.05$800,500.00View SEC Filing  
6/1/2017Kathleen BardwellInsiderSell4,000$79.00$316,000.0020,975View SEC Filing  
6/1/2017Sudhir K PahwaVPSell3,000$79.07$237,210.0022,047View SEC Filing  
5/25/2017Sudhir K. PahwaVPSell800$77.28$61,824.00View SEC Filing  
5/9/2017Michael J TokichCFOSell13,600$76.00$1,033,600.0058,106View SEC Filing  
5/9/2017Sudhir K. PahwaVPSell200$77.00$15,400.00View SEC Filing  
5/3/2017Daniel A CarestioInsiderSell7,590$75.17$570,540.3025,390View SEC Filing  
5/3/2017John Adam ZangerleVPSell3,150$75.00$236,250.0026,639View SEC Filing  
5/3/2017Michael B WoodDirectorSell4,000$75.00$300,000.0030,131View SEC Filing  
5/3/2017Michael J TokichCFOSell2,000$75.00$150,000.0046,506View SEC Filing  
2/13/2017Mohsen SohiDirectorSell3,387$67.66$229,164.4224,421View SEC Filing  
1/17/2017Kathleen BardwellInsiderSell1,962$68.78$134,946.3616,538View SEC Filing  
12/13/2016John Adam ZangerleVPSell3,100$69.00$213,900.0026,589View SEC Filing  
12/8/2016Daniel A CarestioInsiderSell2,225$67.54$150,276.5020,025View SEC Filing  
11/15/2016John Adam ZangerleVPSell2,200$67.00$147,400.0026,166View SEC Filing  
11/4/2016Cynthia L FeldmannDirectorSell4,744$64.98$308,265.1214,581View SEC Filing  
9/7/2016Richard Martin SteevesDirectorSell204,778$71.19$14,578,145.82165,434View SEC Filing  
8/31/2016Adrian Vincent CowardInsiderSell15,000$69.00$1,035,000.00View SEC Filing  
8/26/2016Sudhir K. PahwaVPSell1,028$70.13$72,093.64View SEC Filing  
8/17/2016Walter M. Rosebrough, Jr.CEOSell15,000$71.08$1,066,200.00View SEC Filing  
8/12/2016Daniel A. CarestioInsiderSell2,681$71.04$190,458.24View SEC Filing  
2/17/2016Walter M. Rosebrough, Jr.CEOSell10,000$64.27$642,700.00View SEC Filing  
11/18/2015Walter M Rosebrough JrCEOSell11,960$75.58$903,936.80111,376View SEC Filing  
11/9/2015Kathleen BardwellinsiderSell2,496$73.85$184,329.6013,235View SEC Filing  
11/9/2015Kevin M. McmullenDirectorSell8,000$73.73$589,840.0026,338View SEC Filing  
11/3/2015Mohsen SohiDirectorSell3,000$76.36$229,080.0020,250View SEC Filing  
10/30/2015Daniel A. CarestioinsiderSell6,270$74.00$463,980.0016,800View SEC Filing  
10/28/2015Sudhir K PahwaVPSell1,000$70.09$70,090.0021,289View SEC Filing  
9/30/2015Walter M Rosebrough JrCEOSell5,000$64.92$324,600.00116,376View SEC Filing  
9/29/2015Walter M Rosebrough JrCEOSell10,000$64.43$644,300.00121,376View SEC Filing  
6/15/2015David Allen JohnsonVPSell1,826$63.08$115,184.08View SEC Filing  
6/10/2015Walter M Rosebrough JrCEOSell20,000$63.80$1,276,000.00View SEC Filing  
6/9/2015Walter M Rosebrough JrCEOSell5,000$63.56$317,800.00View SEC Filing  
8/11/2014Michael B WoodDirectorSell5,300$51.79$274,487.00View SEC Filing  
6/2/2014John Adam ZangerleVPSell2,000$53.45$106,900.00View SEC Filing  
5/12/2014John WarehamDirectorSell15,000$55.09$826,350.0023,256View SEC Filing  
4/2/2014Michael TokichCFOSell4,525$51.68$233,852.0030,320View SEC Filing  
1/8/2014Michael TokichCFOSell4,200$48.72$204,624.0030,320View SEC Filing  
11/26/2013Cynthia FeldmannDirectorSell6,254$45.97$287,496.3810,000View SEC Filing  
8/8/2013Timothy ChapmanSVPSell10,000$43.84$438,400.0021,581View SEC Filing  
6/12/2013Kevin M McmullenDirectorSell10,000$44.09$440,900.00View SEC Filing  
5/30/2013Walter M Rosebrough JrCEOSell2,000$45.72$91,440.00View SEC Filing  
5/22/2013Mohsen SohiDirectorSell10,000$45.21$452,100.00View SEC Filing  
5/21/2013William L AamothTreasurerSell6,150$45.96$282,654.00View SEC Filing  
5/13/2013David Allen JohnsonVPSell2,680$44.99$120,573.20View SEC Filing  
10/5/2012Michael J TokichCFOSell4,100$37.00$151,700.00View SEC Filing  
8/9/2012Cynthia L FeldmannDirectorSell23,122$34.05$787,304.10View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Steris (NYSE STE) News Headlines

Source:
DateHeadline
Steris PLC (STE) to Issue Dividend of $0.31Steris PLC (STE) to Issue Dividend of $0.31
www.americanbankingnews.com - February 22 at 12:06 PM
C R Bard (BCR) versus Steris (STE) Critical ComparisonC R Bard (BCR) versus Steris (STE) Critical Comparison
www.americanbankingnews.com - February 19 at 9:10 PM
Contrasting C R Bard (BCR) and Steris (STE)Contrasting C R Bard (BCR) and Steris (STE)
www.americanbankingnews.com - February 18 at 1:10 PM
Steris PLC (STE) Receives Consensus Recommendation of "Buy" from AnalystsSteris PLC (STE) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - February 16 at 1:36 AM
Insider Selling: Steris PLC (STE) VP Sells 1,500 Shares of StockInsider Selling: Steris PLC (STE) VP Sells 1,500 Shares of Stock
www.americanbankingnews.com - February 14 at 9:58 PM
Financial Contrast: LivaNova (LIVN) and Steris (STE)Financial Contrast: LivaNova (LIVN) and Steris (STE)
www.americanbankingnews.com - February 13 at 7:14 PM
Northcoast Research Comments on Steris PLCs Q3 2019 Earnings (STE)Northcoast Research Comments on Steris PLC's Q3 2019 Earnings (STE)
www.americanbankingnews.com - February 12 at 8:28 AM
FY2018 Earnings Forecast for Steris PLC Issued By KeyCorp (STE)FY2018 Earnings Forecast for Steris PLC Issued By KeyCorp (STE)
www.americanbankingnews.com - February 12 at 5:38 AM
Critical Survey: Steris (STE) versus Cryolife (CRY)Critical Survey: Steris (STE) versus Cryolife (CRY)
www.americanbankingnews.com - February 9 at 2:50 PM
FY2018 EPS Estimates for Steris PLC (STE) Increased by AnalystFY2018 EPS Estimates for Steris PLC (STE) Increased by Analyst
www.americanbankingnews.com - February 9 at 12:31 PM
Steris (STE) Stock Rating Reaffirmed by KeyCorpSteris (STE) Stock Rating Reaffirmed by KeyCorp
www.americanbankingnews.com - February 9 at 12:54 AM
Steris (STE) Given a $102.00 Price Target at Northcoast ResearchSteris (STE) Given a $102.00 Price Target at Northcoast Research
www.americanbankingnews.com - February 8 at 3:20 PM
STERIS (STE) Q3 Earnings Beat & Revenues Miss, Margins UpSTERIS (STE) Q3 Earnings Beat & Revenues Miss, Margins Up
www.zacks.com - February 8 at 8:46 AM
Steris (STE) Releases Quarterly  Earnings Results, Beats Estimates By $0.05 EPSSteris (STE) Releases Quarterly Earnings Results, Beats Estimates By $0.05 EPS
www.americanbankingnews.com - February 7 at 9:38 AM
STERIS Announces Financial Results for Fiscal 2018 Third QuarterSTERIS Announces Financial Results for Fiscal 2018 Third Quarter
www.streetinsider.com - February 7 at 9:23 AM
Steris (STE) Issues FY18 Earnings GuidanceSteris (STE) Issues FY18 Earnings Guidance
www.americanbankingnews.com - February 7 at 9:02 AM
 Analysts Anticipate Steris PLC (STE) Will Announce Quarterly Sales of $665.47 Million Analysts Anticipate Steris PLC (STE) Will Announce Quarterly Sales of $665.47 Million
www.americanbankingnews.com - February 7 at 2:16 AM
Steris (STE) to Release Quarterly Earnings on WednesdaySteris (STE) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - January 31 at 1:52 AM
Steris PLC (STE) VP Sudhir K. Pahwa Sells 2,000 SharesSteris PLC (STE) VP Sudhir K. Pahwa Sells 2,000 Shares
www.americanbankingnews.com - January 30 at 6:32 PM
Steris (STE) Downgraded by Zacks Investment ResearchSteris (STE) Downgraded by Zacks Investment Research
www.americanbankingnews.com - January 24 at 4:44 PM
Global sterilization technology market is forecasted to attain $7.5 billion value by 2023Global sterilization technology market is forecasted to attain $7.5 billion value by 2023
www.prnewswire.com - January 24 at 4:33 PM
STERIS to Announce Fiscal 2018 Third Quarter Financial Results on February 7, 2018STERIS to Announce Fiscal 2018 Third Quarter Financial Results on February 7, 2018
finance.yahoo.com - January 24 at 4:33 PM
Steris (STE) Upgraded to Buy by Zacks Investment ResearchSteris (STE) Upgraded to Buy by Zacks Investment Research
www.americanbankingnews.com - January 23 at 1:46 PM
$665.47 Million in Sales Expected for Steris PLC (STE) This Quarter$665.47 Million in Sales Expected for Steris PLC (STE) This Quarter
www.americanbankingnews.com - January 22 at 12:54 PM
Steris PLC (STE) Given Average Recommendation of "Buy" by BrokeragesSteris PLC (STE) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - January 22 at 1:40 AM
Head-To-Head Comparison: ICU Medical (ICUI) vs. Steris (STE)Head-To-Head Comparison: ICU Medical (ICUI) vs. Steris (STE)
www.americanbankingnews.com - January 20 at 7:16 AM
Stocks Generating Improved Relative Strength: SterisStocks Generating Improved Relative Strength: Steris
finance.yahoo.com - January 16 at 11:07 AM
Global Endoscopic Mucosal Resection Market to Reach US$ 2,500 Mn by 2025 - Persistence Market ResearchGlobal Endoscopic Mucosal Resection Market to Reach US$ 2,500 Mn by 2025 - Persistence Market Research
www.prnewswire.com - January 9 at 10:58 AM
BRIEF-STERIS Plc Sees U.S. Tax Cuts And Jobs Act To Result In Tax Gain Of About $25 Mln In Q3 Fiscal 2018BRIEF-STERIS Plc Sees U.S. Tax Cuts And Jobs Act To Result In Tax Gain Of About $25 Mln In Q3 Fiscal 2018
www.reuters.com - January 8 at 9:01 AM
Is It Too Late To Buy Steris Plc (NYSE:STE)?Is It Too Late To Buy Steris Plc (NYSE:STE)?
finance.yahoo.com - January 4 at 11:01 AM
Steris (STE) Rating Reiterated by Raymond James FinancialSteris (STE) Rating Reiterated by Raymond James Financial
www.americanbankingnews.com - January 3 at 8:52 AM
 Analysts Expect Steris PLC (STE) to Post $1.07 EPS Analysts Expect Steris PLC (STE) to Post $1.07 EPS
www.americanbankingnews.com - January 3 at 3:08 AM
STERIS Plc :STE-US: Earnings Analysis: Q2, 2018 By the Numbers : January 1, 2018STERIS Plc :STE-US: Earnings Analysis: Q2, 2018 By the Numbers : January 1, 2018
finance.yahoo.com - January 1 at 10:52 AM
Zacks Investment Research Upgrades Steris (STE) to HoldZacks Investment Research Upgrades Steris (STE) to Hold
www.americanbankingnews.com - December 29 at 1:26 PM
Steris PLC (STE) Given Average Rating of "Buy" by AnalystsSteris PLC (STE) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - December 28 at 2:12 AM
Financial Survey: Steris (STE) vs. Antares Pharma (ATRS)Financial Survey: Steris (STE) vs. Antares Pharma (ATRS)
www.americanbankingnews.com - December 25 at 1:18 PM
STERIS Plc is trading above its 50 day moving average : STE-US : December 21, 2017STERIS Plc is trading above its 50 day moving average : STE-US : December 21, 2017
finance.yahoo.com - December 21 at 11:07 AM
Zacks: Analysts Anticipate Steris PLC (STE) Will Post Quarterly Sales of $665.47 MillionZacks: Analysts Anticipate Steris PLC (STE) Will Post Quarterly Sales of $665.47 Million
www.americanbankingnews.com - December 19 at 9:06 AM
$1.07 EPS Expected for Steris PLC (STE) This Quarter$1.07 EPS Expected for Steris PLC (STE) This Quarter
www.americanbankingnews.com - December 17 at 1:26 PM
STERIS to Participate in the J.P. Morgan Healthcare ConferenceSTERIS to Participate in the J.P. Morgan Healthcare Conference
finance.yahoo.com - December 15 at 11:39 AM
Medical Sterilization Equipment Market CAGR of 7.15% by Value During 2017 - 2022 | ReportsnReportsMedical Sterilization Equipment Market CAGR of 7.15% by Value During 2017 - 2022 | ReportsnReports
finance.yahoo.com - December 12 at 3:57 PM
Comparing AtriCure (ATRC) and Steris (STE)Comparing AtriCure (ATRC) and Steris (STE)
www.americanbankingnews.com - December 9 at 9:36 AM
STERIS Plc breached its 50 day moving average in a Bearish Manner : STE-US : December 6, 2017STERIS Plc breached its 50 day moving average in a Bearish Manner : STE-US : December 6, 2017
finance.yahoo.com - December 6 at 11:31 AM
Steris Plc (STE) Given Consensus Rating of "Buy" by AnalystsSteris Plc (STE) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - December 3 at 1:48 AM
Steris Plc (STE) Expected to Announce Quarterly Sales of $665.47 MillionSteris Plc (STE) Expected to Announce Quarterly Sales of $665.47 Million
www.americanbankingnews.com - December 1 at 8:19 AM
Zacks: Analysts Expect Steris Plc (STE) to Post $1.07 Earnings Per ShareZacks: Analysts Expect Steris Plc (STE) to Post $1.07 Earnings Per Share
www.americanbankingnews.com - November 29 at 5:26 AM
Head-To-Head Review: Lombard Medical (EVARF) versus Steris (STE)Head-To-Head Review: Lombard Medical (EVARF) versus Steris (STE)
www.americanbankingnews.com - November 28 at 1:38 AM
STERIS Plc : STE-US: Dividend Analysis : November 22nd, 2017 (record date) : By the numbers : November 22, 2017STERIS Plc : STE-US: Dividend Analysis : November 22nd, 2017 (record date) : By the numbers : November 22, 2017
finance.yahoo.com - November 23 at 2:33 PM
Sterilization Technology Market to Reach $7.5 Billion by 2023: P&S Market ResearchSterilization Technology Market to Reach $7.5 Billion by 2023: P&S Market Research
globenewswire.com - November 20 at 10:31 AM
John Adam Zangerle Sells 3,650 Shares of Steris Plc (STE) StockJohn Adam Zangerle Sells 3,650 Shares of Steris Plc (STE) Stock
www.americanbankingnews.com - November 15 at 8:22 PM

SEC Filings

Steris (NYSE:STE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Steris (NYSE:STE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Steris (NYSE STE) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.